CBD Co. Zynerba, Investors Seek OK For $4M Settlement Deal

Law360 (May 3, 2021, 5:13 PM EDT) -- Investors in CBD drugmaker Zynerba Pharmaceuticals have asked a federal judge in Pennsylvania to approve a $4 million settlement deal that would end claims that the company withheld unfavorable information about a clinical trial for a drug candidate.

In a Friday motion, lead plaintiffs Scott Whiteley and Harry Berger told U.S. District Judge Nitza I. Quiñones Alejandro that Zynerba's insurer would pay the multimillion dollar settlement sum, which they characterized as "an excellent result" for the settlement class.

"So long as the settlement appears prima facie reasonable, co-lead counsel request that the court preliminarily approve the settlement," the investors said....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Attached Documents

Related Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Subscribers Only

Nature of Suit

Subscribers Only

Judge

Subscribers Only

Date Filed

Subscribers Only

Law Firms

Government Agencies

Judge Analytics

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!